Predictive Oncology

NASDAQ: POAI
Nasdaq Stock Market
Healthcare Medical Instruments & Supplies
Global Rank
#41389
Country Rank
#5123
Market Cap
10.24 M
Price
14.1
Change (%)
0.00%
Volume
106,398

Predictive Oncology (NASDAQ: POAI) Stock Split History

Date Split Ratio Multiple Cumulative multiple Type
09/30/2025 1:15 x0.06666667 x0.0000001777304 Reverse
04/24/2023 1:20 x0.05 x0.000002665956 Reverse
10/29/2019 1:10 x0.1 x0.00005331912 Reverse
10/28/2016 1:25 x0.04 x0.0005331912 Reverse
10/28/2014 1:75.02 x0.01332978 x0.01332978 Reverse

Frequently Asked Questions

  • How much would Predictive Oncology stock be worth if it never split?
    If Predictive Oncology (stock symbol: NASDAQ: POAI) had never undergone any stock splits, its price per share today would be approximately 0.00 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1-for-15) that occurred on 09/30/2025.
  • Predictive Oncology (stock symbol: NASDAQ: POAI) has undergone a total of five stock splits. The most recent split occurred on 09/30/2025. One share bought prior to the first split on 10/28/2014 would now equal 0.00 shares.
  • Predictive Oncology (stock symbol: NASDAQ: POAI) has undergone five stock splits in its history. The most recent split, a 1-for-75.02 split, occurred on 09/30/2025. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.